Thursday, December 26, 2024
Type:
Filter by Org Category:
Filter By Name:
Health Care | Pharmaceutical Companies
Most recent 10/03/21 - Japan’s MHLW Approves Pfizer’s CIBINQO® (abrocitinib) for Adults and Adolescents with Moderate to Severe Atopic Dermatitis